Bioethics in the News — August 25
August 25, 2006
- Morning-after pill soon will appear on shelves (Chicago Tribune)
- UK: ‘Designer baby’ fund hits £20,000 (BBC)
- Why the Stem Cell Advance May Not Be a Breakthrough (The Times)
- Organ trade in China raises alarm over human rights (St. Louis Post-Dispatch)
- Glaxo in Deal to Develop New Drugs (Reuters)
- Biotech hopes to woo investors with stem cell research advance (AP)
- Op-Ed: Stem cell ‘breakthrough’ more hype than hope (MSNBC)